Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AVTR✓SelectedUSD · AVTRGSK vs AVTR performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs AVTR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.9%
AVTR return
-21.8%
Excess return
+74.8%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioAVTRExcessAlpha
1D-1.6%-1.6%+0.1%-1.4%
7D-4.7%-3.2%-1.5%-4.4%
30D-4.7%-9.0%+4.3%-3.8%
3M-8.8%+8.3%-17.1%-9.5%
6M-4.6%+97.9%-102.5%-11.4%
YTD+1.0%+31.9%-30.9%-2.5%
1Y+6.9%+37.3%-30.5%+2.8%
All+52.9%-21.8%+74.8%+59.2%

Cumulative growth

Daily Returns

Daily percentage return beside AVTR.

Daily Out/Under-Performance

Portfolio return minus AVTR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AVTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded AVTR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling